<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Radiopharm Theranostics Expands Share Issuance to Bolster Market Position

PremiumCompany Announcements

3d ago

Radiopharm Theranostics Announces New Securities Quotation on ASX

PremiumCompany Announcements

3d ago

Radiopharm Theranostics Announces New Securities Quotation on ASX

PremiumCompany Announcements

3d ago

Radiopharm Theranostics Limited Holdings Concentration Revealed

PremiumCompany Announcements

3d ago

PremiumCompany AnnouncementsRadiopharm Theranostics Successfully Passes All Resolutions at General Meeting

9d ago

Radiopharm Theranostics Completes Share Purchase Plan

Company Announcements

Radiopharm Theranostics Completes Share Purchase Plan

9d ago

JPMorgan Chase & Co. Ceases Substantial Holding in Radiopharm Theranostics

Company Announcements

JPMorgan Chase & Co. Ceases Substantial Holding in Radiopharm Theranostics

11d ago

Radiopharm price target lowered to $13 from $15 at B. Riley

PremiumThe Fly

15d ago

Radiopharm Theranostics Announces Expiry of Restricted Options

PremiumCompany Announcements

17d ago

Radiopharm Theranostics Announces Director Change

PremiumCompany Announcements

17d ago

Radiopharm Theranostics Announces Director Departure

PremiumCompany Announcements

17d ago

PremiumCompany AnnouncementsRadiopharm Theranostics Secures Strong Backing at AGM

22d ago

Radiopharm Theranostics Highlights Key Investor Considerations at AGM

Company Announcements

Radiopharm Theranostics Highlights Key Investor Considerations at AGM

22d ago

Radiopharm Theranostics Appoints New Director

Company Announcements

Radiopharm Theranostics Appoints New Director

23d ago

Radiopharm Theranostics Strengthens Board with Appointment of Bruce Goodwin

PremiumCompany Announcements

23d ago

Radiopharm receives approval to initiate Phase 1 trial of RAD 402

PremiumThe Fly

23d ago

Radiopharm Theranostics Gains Approval for Phase 1 Trial of RAD 402 in Prostate Cancer

PremiumCompany Announcements

24d ago

Radiopharm announces 50% enrollment in Phase 2b trial of RAD101

PremiumThe Fly

24d ago

PremiumCompany AnnouncementsRadiopharm Theranostics Achieves 50% Enrollment in Phase 2b Trial for Brain Metastases Imaging

25d ago

Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204

The Fly

Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204

29d ago

Radiopharm Theranostics Advances Phase 1 Trial for Innovative Cancer Treatment

Company Announcements

Radiopharm Theranostics Advances Phase 1 Trial for Innovative Cancer Treatment

30d ago